A PilOt Dose-escalation Trial With EMP16 in Preparation for Phase III - the POEM Trial
Latest Information Update: 03 Jun 2025
At a glance
- Drugs Acarbose/orlistat (Primary) ; Orlistat (Primary) ; Maltodextrin
- Indications Obesity
- Focus Therapeutic Use
- Acronyms POEM
- Sponsors Empros Pharma
Most Recent Events
- 03 Jun 2025 New trial record